Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
Previous studies suggest that protective immunity against Schistosoma haematobium is primarily stimulated by antigens from dying worms. Praziquantel treatment kills adult worms, boosting antigen exposure and protective antibody levels. Current schistosomiasis control efforts use repeated mass drug a...
Saved in:
| Main Authors: | Kate M Mitchell, Francisca Mutapi, Takafira Mduluza, Nicholas Midzi, Nicholas J Savill, Mark E J Woolhouse |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0003059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory and activated T cells in human Schistosoma haematobium infections.
by: Norman Nausch, et al.
Published: (2011-02-01) -
Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium
by: Liam Reilly, et al.
Published: (2012-01-01) -
Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012-01-01) -
Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.
by: Gemma Louise Kay, et al.
Published: (2015-01-01) -
Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection.
by: Norman Nausch, et al.
Published: (2012-01-01)